
HCA Healthcare, Inc.

HCA (HCA Healthcare, Inc.) trades at 2.1x EV/Revenue — attractively valued for a healthcare & pharma company with solid margins (42%) and mature growth profile. The business is profitable at 21% EBIT margins. Forward PE of 16x.
The S&P 500 has returned an average of 10.7% annually since 1926 — but only 6 of those years actually returned between 8-12%.
Gold Eagle provides data and AI-generated analysis for informational purposes only. Not investment advice. All data from public sources.
HCA Healthcare operates one of the nation's largest networks of acute care facilities, running approximately 180 hospitals and 2,000 care sites across 20 states and the United Kingdom. They provide essential medical services ranging from emergency care to complex surgeries, generating revenue through patient admissions, outpatient procedures, and insurance reimbursements from both private payers and government programs like Medicare and Medicaid.
HCA has delivered mid-to-high single-digit revenue growth driven by same-facility admissions growth and strategic market expansion. The company benefits from population growth in its key Sun Belt markets and continues to invest in facility upgrades and technology to capture increasing healthcare utilization as demographics shift toward an older population requiring more intensive medical services.
The company maintains strong operating leverage with EBITDA margins typically in the high-teens to low-20% range, though recent quarters have seen margin pressure from elevated labor costs. HCA generates substantial free cash flow conversion, historically returning 15-20% of its market cap annually to shareholders through dividends and buybacks, demonstrating disciplined capital allocation.
HCA's scale advantages in purchasing, technology investments, and recruiting enable it to compete effectively against both non-profit health systems and smaller for-profit operators. The company's geographic clustering strategy creates local market density that's difficult for competitors to replicate, while its financial resources allow for continued investment in advanced medical equipment and facility improvements.
Without access to recent financial data, HCA's performance would typically be measured against key metrics like same-facility admissions growth, revenue per admission trends, and progress on labor cost management. Hospital operators have generally faced headwinds from staffing challenges while benefiting from normalized patient volumes post-COVID.
Analyst sentiment on hospital operators typically focuses on the balance between volume recovery, pricing power with insurers, and cost management execution. Coverage generally emphasizes HCA's market leadership position and cash generation capabilities while monitoring labor cost trends and regulatory developments that could impact reimbursement rates.
HCA represents the gold standard in for-profit hospital operations with unmatched scale, strong cash generation, and exposure to favorable demographic trends, though investors must weigh these strengths against ongoing industry headwinds from labor inflation and regulatory pressures.








| '25E | '26E | '27E | '28E | |
|---|---|---|---|---|
| Revenue | — | $78.6B | $82.4B | $86.9B |
| Growth | — | +5% | +5% | |
| EBITDA | — | $16.7B | $17.5B | $18.5B |
| Growth | — | +5% | +5% | |
| EPS (PF) | — | $30.27 | $33.30 | $37.30 |
| Growth | — |
HCA Healthcare Named as One of the 2026 World's Most Ethical Companies by Ethisphere
HCA Healthcare, Inc. (HCA) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
HCA Healthcare, Inc. (HCA) Presents at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Transcript
HCA Stock: How Probing Positions Help Patient Investors In Sideways Market
HCA Healthcare, Inc. (HCA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
| +10% |
| +12% |